23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bilirubin inhibits the up-regulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the toll-like receptor 4-dependent activation of NADPH oxidase

      research-article
      , , *
      Redox Biology
      Elsevier
      Aryl hydrocarbon receptor (AhR), Bilirubin, Hypoxia-inducible factor (HIF), NADPH oxidase, Nitric oxide synthase, Toll-like receptor 4 (TLR4), Superoxide, AhR, aryl hydrocarbon receptor, ARNT, aryl hydrocarbon receptor nuclear translocator, Cyp1A1, cytochrome P450, family 1, subfamily A, polypeptide 1, HE, hydroethidine, HIF-1α, hypoxia inducible factor-1α, iNOS, inducible nitric oxide synthase, IL-6, interleukin-6, Inf-β, interferon-β, IRF3, interferon regulatory factor 3, ISRE, interferon-sensitive response element, MyD88, myeloid differentiation factor-88, Nox, NADPH oxidase, PMA, phorbol myristate acetate, ROS, reactive oxygen species, SOD, superoxide dismutase, TEMPOL, 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl, TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin, TLR4, toll-like receptor-4, TNFα, tumor necrosis factor-α

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          It has been previously shown that bilirubin prevents the up-regulation of inducible nitric oxide synthase (iNOS) in response to LPS. The present study examines whether this effect is exerted through modulation of Toll-Like Receptor-4 (TLR4) signaling. LPS-stimulated iNOS and NADPH oxidase (Nox) activity in RAW 264.7 murine macrophages was assessed by measuring cellular nitrate and superoxide ( O 2 ) production, respectively. The generation of both nitrate and O 2 in response to LPS was suppressed by TLR4 inhibitors, indicating that activation of iNOS and Nox is TLR4-dependent. While treatment with superoxide dismutase (SOD) and bilirubin effectively abolished LPS-mediated O 2 production, hydrogen peroxide and nitrate release were inhibited by bilirubin and PEG-catalase, but not SOD, supporting that iNOS activation is primarily dependent upon intracellular H 2O 2. LPS treatment increased nuclear translocation of the redox-sensitive transcription factor Hypoxia Inducible Factor-1α (HIF-1α), an effect that was abolished by bilirubin. Cells transfected with murine iNOS reporter constructs in which the HIF-1α-specific hypoxia response element was disrupted exhibited a blunted response to LPS, supporting that HIF-1α mediates Nox-dependent iNOS expression. Bilirubin, but not SOD, blocked the cellular production of interferon-β, while interleukin-6 production remained unaffected. These data support that bilirubin inhibits the TLR4-mediated up-regulation of iNOS by preventing activation of HIF-1α through scavenging of Nox-derived reactive oxygen species. Bilirubin also suppresses interferon-β release via a ROS-independent mechanism. These findings characterize potential mechanisms for the anti-inflammatory effects of bilirubin.

          Graphical abstract

          Highlights

          • Bilirubin blocks TLR4 signaling by scavenging NADPH oxidase-derived reactive oxygen species.

          • Bilirubin specifically inhibits the TRIF-dependent TLR4 signaling pathway.

          • LPS activation of inducible nitric oxide synthase is mediated by HIF-1α.

          • Macrophages exhibit reciprocal regulation of HIF-1α and aryl hydrocarbon receptor pathways.

          • Potential mechanisms underlying the anti-inflammatory effects of bilirubin are delineated.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: not found

          Bilirubin is an antioxidant of possible physiological importance.

          Bilirubin, the end product of heme catabolism in mammals, is generally regarded as a potentially cytotoxic, lipid-soluble waste product that needs to be excreted. However, it is here that bilirubin, at micromolar concentrations in vitro, efficiently scavenges peroxyl radicals generated chemically in either homogeneous solution or multilamellar liposomes. The antioxidant activity of bilirubin increases as the experimental concentration of oxygen is decreased from 20% (that of normal air) to 2% (physiologically relevant concentration). Furthermore, under 2% oxygen, in liposomes, bilirubin suppresses the oxidation more than alpha-tocopherol, which is regarded as the best antioxidant of lipid peroxidation. The data support the idea of a "beneficial" role for bilirubin as a physiological, chain-breaking antioxidant.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Biliverdin reductase: a major physiologic cytoprotectant.

            Bilirubin, an abundant pigment that causes jaundice, has long lacked any clear physiologic role. It arises from enzymatic reduction by biliverdin reductase of biliverdin, a product of heme oxygenase activity. Bilirubin is a potent antioxidant that we show can protect cells from a 10,000-fold excess of H2O2. We report that bilirubin is a major physiologic antioxidant cytoprotectant. Thus, cellular depletion of bilirubin by RNA interference markedly augments tissue levels of reactive oxygen species and causes apoptotic cell death. Depletion of glutathione, generally regarded as a physiologic antioxidant cytoprotectant, elicits lesser increases in reactive oxygen species and cell death. The potent physiologic antioxidant actions of bilirubin reflect an amplification cycle whereby bilirubin, acting as an antioxidant, is itself oxidized to biliverdin and then recycled by biliverdin reductase back to bilirubin. This redox cycle may constitute the principal physiologic function of bilirubin.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

              A large body of literature suggest that vascular reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases are important sources of reactive oxygen species. Many studies, however, relied on data obtained with the inhibitor apocynin (4'-hydroxy-3'methoxyacetophenone). Because the mode of action of apocynin, however, is elusive, we determined its mechanism of inhibition on vascular NADPH oxidases. In HEK293 cells overexpressing NADPH oxidase isoforms (Nox1, Nox2, or Nox4), apocynin failed to inhibit superoxide anion generation detected by lucigenin chemiluminescence. In contrast, apocynin interfered with the detection of reactive oxygen species in assay systems selective for hydrogen peroxide or hydroxyl radicals. Importantly, apocynin interfered directly with the detection of peroxides but not superoxide, if generated by xanthine/xanthine oxidase or nonenzymatic systems. In leukocytes, apocynin is a prodrug that is activated by myeloperoxidase, a process that results in the formation of apocynin dimers. Endothelial cells and smooth muscle cells failed to form these dimers and, therefore, are not able to activate apocynin. Dimer formation was, however, observed in Nox-overexpressing HEK293 cells when myeloperoxidase was supplemented. As a consequence, apocynin should only inhibit NADPH oxidase in leukocytes, whereas in vascular cells, the compound could act as an antioxidant. Indeed, in vascular smooth muscle cells, the activation of the redox-sensitive kinases p38-mitogen-activate protein kinase, Akt, and extracellular signal-regulated kinase 1/2 by hydrogen peroxide and by the intracellular radical generator menadione was prevented in the presence of apocynin. These observations indicate that apocynin predominantly acts as an antioxidant in endothelial cells and vascular smooth muscle cells and should not be used as an NADPH oxidase inhibitor in vascular systems.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                29 June 2015
                August 2015
                29 June 2015
                : 5
                : 398-408
                Affiliations
                [0005]Division of Digestive Diseases, University of Cincinnati, Cincinnati, OH 45267-0595, USA
                Author notes
                [* ]Correspondence to: Division of Digestive Diseases, University of Cincinnati, 231 Albert B. Sabin Way, MSB 7262B, Cincinnati, OH, 45267-0595 USA. Fax: +1 513 558 1744. zuckersd@ 123456ucmail.uc.edu
                Article
                S2213-2317(15)00059-2
                10.1016/j.redox.2015.06.008
                4506991
                26163808
                9fdc4b4c-e148-48d0-8d91-874b249df38d
                © 2015 Published by Elsevier B.V.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 14 June 2015
                : 15 June 2015
                Categories
                Research Paper

                aryl hydrocarbon receptor (ahr),bilirubin,hypoxia-inducible factor (hif),nadph oxidase,nitric oxide synthase,toll-like receptor 4 (tlr4),superoxide,ahr, aryl hydrocarbon receptor,arnt, aryl hydrocarbon receptor nuclear translocator,cyp1a1, cytochrome p450, family 1, subfamily a, polypeptide 1,he, hydroethidine,hif-1α, hypoxia inducible factor-1α,inos, inducible nitric oxide synthase,il-6, interleukin-6,inf-β, interferon-β,irf3, interferon regulatory factor 3,isre, interferon-sensitive response element,myd88, myeloid differentiation factor-88,nox, nadph oxidase,pma, phorbol myristate acetate,ros, reactive oxygen species,sod, superoxide dismutase,tempol, 4-hydroxy-2,2,6,6-tetramethylpiperidine-n-oxyl,tcdd, 2,3,7,8-tetrachlorodibenzo-p-dioxin,tlr4, toll-like receptor-4,tnfα, tumor necrosis factor-α

                Comments

                Comment on this article